SCHEMBL18243769

SCHEMBL18243769

CCC(=O)CCSC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
CES2 O00748 5/20 0.44
CES1 P23141 5/20 0.44
GPR139 Q6DWJ6 1/20 0.42
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 2/20 0.40
HSD11B1 P28845 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12154245 0.81 KMT2A (0.48) KMT2ACES2CES1GPR139ALDH1A1
SCHEMBL8309337 0.81 NR4A2 (0.52) KMT2ACES1GPR139ALDH1A1SMN1; SMN2
SCHEMBL6057351 0.81 KMT2A (0.50) KMT2ACES2CES1GPR139ALDH1A1
SCHEMBL16047247 0.80 KMT2A (0.52) KMT2ACES2CES1GPR139ALDH1A1
SCHEMBL18244312 0.79 MAPT (0.55) KMT2ACES1ALDH1A1SMN1; SMN2NPC1
SCHEMBL18113163 0.78 POLB (0.49) KMT2AALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL7290449 0.78 KMT2A (0.45) KMT2ACES2CES1GPR139ALDH1A1
SCHEMBL6057163 0.78 ALDH1A1 (0.57) KMT2ACES2CES1GPR139ALDH1A1
SCHEMBL18243806 0.77 AKT1 (0.50) KMT2AGPR139ALDH1A1SMN1; SMN2MAPT
SCHEMBL1641518 0.77 HDAC3 (0.55) KMT2ACES2CES1GPR139ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9567297-B2 Method for synthesizing of thioesters by using compound as catalyst NATIONAL CENTRAL UNIVERSITY (TW) 2017-02-14 US disclosed
US-9567297-B2 Method for synthesizing of thioesters by using compound as catalyst NATIONAL CENTRAL UNIVERSITY (TW) 2017-02-14 US disclosed
US-9567297-B2 Method for synthesizing of thioesters by using compound as catalyst NATIONAL CENTRAL UNIVERSITY (TW) 2017-02-14 US disclosed
US-20160340303-A1 Method for Synthesizing of Thioesters by Using Compound as Catalyst NATIONAL CENTRAL UNIVERSITY 2016-11-24 US disclosed
US-20160340303-A1 Method for Synthesizing of Thioesters by Using Compound as Catalyst NATIONAL CENTRAL UNIVERSITY 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340303-A1 Method for Synthesizing of Thioesters by Using Compound as Catalyst ACOT7, TST, STS KMT2A 1756/4885CES2 164/4885CES1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.